When to pause an offer

Pause and ask for an explanation

• No prescription is requested

  Federal law still barred supplying prescription medicine with no valid prescription in September 2026.

• The medicine maker’s name stays hidden

  A medicine prepared to order is a compounded drug.

  The Food and Drug Administration (FDA) warned in September 2026 that online care patients may not know who made their compounded drug.

  Ask for the name in writing, then check the state record.

• Approval claims do not match the product

  In the September 2026 check, FDA rejected claims that a compounded drug has FDA approval or is identical to an approved product.

  Ask for the finished product’s actual status.

• A badge or code stands in for an answer

  FDA registration and a drug listing code do not establish product approval, as checked in September 2026.

• A research label is offered as treatment

  Washington’s pharmacy commission said in July 2026 that research-labelled ingredients cannot go into drugs compounded for patient use.

  According to FDA’s position checked in September 2026, federal law bars compounding either retatrutide or cagrilintide.

Ask what happens after the medicine arrives

FDA’s consumer checklist flags a service if patients cannot ask a licensed doctor questions after receiving their medicine.

Ask who answers, how to reach them, and how a concern becomes an actual care conversation. Keep the answer with the quote.